Project Grant R01AI195926
Award Date 4/23/26
Completion Date 3/31/31
Dollars Obligated $796K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia a $1,201,716 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 6, 2025, for research titled "Chemical Grammar of Accumulation in Drug Resistant Acinetobacter baumannii with Subcellular Resolution." The project, with performance in Charlottesville, Virginia, and completion scheduled for July 31, 2030, will develop...
- Federal Grant Award Summary The University of Virginia received a $806,000 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 11, 2026, with a completion date of April 30, 2031. The award supports investigative research examining the role of secreted bacterial effectors—specifically Type VII secretion systems (T7SS) and their effector proteins—in Group B Streptococcus (GBS)-induced...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia $155,216 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on November 23, 2025, for a project period extending through June 30, 2029. This F30 fellowship grant supports doctoral research investigating norepinephrine-mediated resistance mechanisms in Neisseria gonorrhoeae (GC), the bacterial pathogen responsible for gonorrhea. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia a $773,388 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning April 1, 2026, with a completion date of March 31, 2031. This five-year research initiative, titled "Decoding Cellular Networks Governing Respiratory Mucosal IgA Immunity," will investigate the cellular and molecular mechanisms that drive robust...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Miami a Project Grant of $617,438 (awarded April 1, 2026, with completion by March 31, 2030) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a rapid, cell-based diagnostic and antibiotic susceptibility test for urinary tract infections (UTIs). The project addresses the critical healthcare challenge of diagnosing bacterial UTIs and identifying...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a Project Grant of $115,123.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 20, 2025, with a completion date of July 31, 2027. This research project, titled "Inside Out: Revealing Strategies for Intracellular S. Aureus Persister Eradication," addresses the critical challenge of antibiotic-tolerant...
- Federal Grant Award Summary The University of Virginia received a $146,170 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 9, 2025 through April 30, 2030. This award supports the development of a global infectious diseases research framework designed to advance interdisciplinary collaboration among junior faculty and researchers engaged in global health...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $109,476 to the University of Wisconsin-Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on November 30, 2025, with a completion date of May 31, 2027. This Project Grant supports fundamental research to understand the molecular mechanisms governing drug efflux in bacterial multidrug resistance transporters, specifically the NorA pump. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Children's Hospital of Philadelphia $881,303 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 17, 2025, for a project extending through June 30, 2030. This Project Grant funds a comprehensive research initiative utilizing whole genome sequencing (WGS) and diagnostic allele (DA) surveillance to track pathogen transmission and infection dynamics in neonatal...
- Federal Grant Award Summary Emory University received a $161,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 16, 2026, with completion targeted for March 31, 2028. The research focuses on understanding multidrug-resistant pathogen infections and elucidating the evolutionary trajectories of antibiotic resistance in three clinically significant bacteria: Staphylococcus...